SCHEMBL27735688

SCHEMBL27735688

CCCC(=O)On1nc(I)c2cccnc21

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ELANE P08246 6/20 0.41
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ FEN1 P39748 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ GSK3A P49840 1/20 0.35
▸ GSK3B P49841 1/20 0.35
▸ PDE4A P27815 1/20 0.35
▸ PDE4B Q07343 1/20 0.35
▸ PDE4C Q08493 1/20 0.35
▸ PDE4D Q08499 1/20 0.35
▸ RECQL P46063 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ KDM4A O75164 1/20 0.34
▸ KDM4C Q9H3R0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27735636 0.86 L3MBTL1 (0.46) ELANEMEN1KMT2AL3MBTL1SMN1; SMN2
SCHEMBL27714808 0.82 ELANE (0.40) ELANEMEN1KMT2AL3MBTL1SMN1; SMN2
SCHEMBL27735638 0.78 GSK3A (0.40) ELANEMEN1KMT2AL3MBTL1GSK3A
SCHEMBL27735648 0.76 HSD17B10 (0.35) MEN1KMT2AL3MBTL1SMN1; SMN2LMNA
SCHEMBL1639394 0.74 MEN1 (0.53) MEN1KMT2AL3MBTL1SMN1; SMN2RECQL
SCHEMBL12726462 0.70 L3MBTL1 (0.40) ELANEFEN1L3MBTL1SMN1; SMN2
SCHEMBL1639426 0.70 KDM4E (0.44) MEN1KMT2AFEN1L3MBTL1GSK3B
SCHEMBL1639832 0.70 ALOX15 (0.43) ELANEFEN1L3MBTL1
SCHEMBL27714800 0.68 ALDH1A1 (0.43) ELANEMEN1KMT2AFEN1L3MBTL1
SCHEMBL10063584 0.68 FEN1 (0.44) ELANEFEN1L3MBTL1GSK3BPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101242839-A Azaindazole compounds and methods of use CHEMOCENTRYX INC (US) 2008-08-13 — — CN disclosed
Send feedback